Anti-Ferroptotic Treatment Deteriorates Myocardial Infarction by Inhibiting Angiogenesis and Altering Immune Response
Mammalian cardiomyocytes have limited regenerative ability. Cardiac disease, such as congenital heart disease and myocardial infarction, causes an initial loss of cardiomyocytes through regulated cell death (RCD). Understanding the mechanisms that govern RCD in the injured myocardium is crucial for...
Saved in:
Main Authors: | Rebecca A. Stairley (Author), Allison M. Trouten (Author), Shuang Li (Author), Patrick L. Roddy (Author), Kristine Y. DeLeon-Pennell (Author), Kyu-Ho Lee (Author), Henry M. Sucov (Author), Chun Liu (Author), Ge Tao (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammation in a ferroptotic environment
by: Anja Wickert, et al.
Published: (2024) -
Pyrroloquinoline quinone modulates YAP-related anti-ferroptotic activity to protect against myocardial hypertrophy
by: Jiabin Zhou, et al.
Published: (2022) -
Gastrin exerts a protective effect against myocardial infarction via promoting angiogenesis
by: Jinjuan Fu, et al.
Published: (2021) -
Angiogenesis and expression of vascular endothelial growth factor and endostatin protein in myocardial infarction rat model
by: Chenglong Zheng, et al.
Published: (2016) -
Symmetric Dimethylarginine is Altered in Patients After Myocardial Infarction and Predicts Adverse Outcomes
by: Gąsecka A, et al.
Published: (2021)